Transposon Therapeutics, Inc. (United States)
Transposon Therapeutics, Inc.
Transposon Therapeutics, Inc. is developing TPN-101 (also known as Censavudine) and other LINE-1 reverse transcriptase inhibitors for the treatment of rare neurodegenerative diseases such as progressive supranuclear palsy (PSP), amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD).
Company details
- Address
- United States
- Website
- transposonrx.com
Reviews
No reviews yet.
All reviews of Transposon Therapeutics, Inc. (United States) · Write a review
Domain and WHOIS record
- Domain
- transposonrx.com
- Registrar
- GoDaddy.com, LLC
- Registered
- 6 Dec 2019
- Expires
- 6 Dec 2026
- Record updated
- 7 Dec 2024
- Name servers
- ns39.domaincontrol.com, ns40.domaincontrol.com
- DNSSEC
- Not signed